34 studies found for:    " August 21, 2013":" September 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Recruiting CCTG 593: Testing and Linkage to Care
Conditions: HIV Positive;   HIV Seronegative
Intervention: Behavioral: Linkage to PrEP or Care
2 Recruiting CCTG 594: Engagement and Retention in Care for HIV+
Conditions: Patient Adherence;   HIV Positive
Intervention: Behavioral: SoC + ALERT Intervention
3 Recruiting Effect of Cenicriviroc on HIV Neurocognitive Impairment
Conditions: AIDS Dementia Complex;   HIV-1-Associated Cognitive Motor Complex;   Human Immunodeficiency Virus
Intervention: Drug: cenicriviroc
4 Completed Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Disulfiram
5 Recruiting A Two Part, Open-label Study to Evaluate the Safety and Effectiveness of ABT-450/r/ABT-267 or ABT-450/r/ABT-267 and ABT-333 Given With or Without a Drug Called Ribavirin in People With Both Hepatitis C Virus Genotype 1 or 4 Infection and Human Immunodeficiency Virus, Type 1 Infection
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
6 Recruiting Observational Study of HIV-associated Neurocognitive Disorder
Conditions: HIV Associated Neurocognitive Disorder;   Human Immunodeficiency Virus
Intervention:
7 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
8 Recruiting Evaluating Safety and Effectiveness of Low-Dose Methotrexate at Reducing Inflammation in HIV-Infected Adults Taking Antiretroviral Medications
Condition: HIV Infections
Interventions: Drug: Methotrexate (MTX);   Drug: Placebo;   Dietary Supplement: Folic acid
9 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
10 Recruiting The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
Condition: HIV
Intervention: Behavioral: Trained Mentor Mother and Supervisor
11 Completed Determining the Barriers and Motivations to Clinical Trial Participation
Condition: HIV
Intervention:
12 Recruiting ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
Condition: HIV
Interventions: Other: Point of care CD4+ after HIV diagnosis;   Other: Accelerated ART initiation;   Behavioral: SMS appointment reminders;   Other: Non-cash Financial Incentives
13 Recruiting Patient-Centered Disclosure Intervention for HIV-Infected Children
Condition: HIV
Intervention: Behavioral: HADITHI Intervention
14 Completed mHealth Intervention Supporting HIV Treatment Adherence and Retention
Conditions: HIV;   Adherence;   mHealth;   Retention
Intervention: Other: Text messaging
15 Recruiting Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
Condition: HIV
Intervention: Other: MCH-focused ART services
16 Recruiting Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
Condition: HIV Disease
Intervention: Drug: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)
17 Completed Vertical Transmission Study
Condition: HIV
Intervention: Behavioral: Infant feeding counselling and support
18 Active, not recruiting Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Condition: HIV-1 Infection
Intervention: Drug: Pegylated Interferon alpha 2b
19 Recruiting S1204, Viral Screening in Newly Diagnosed Cancer Patients
Condition: Cancer
Intervention:
20 Not yet recruiting Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)
Conditions: HIV;   Substance Related Disorders
Interventions: Drug: Buprenorphine/naloxone;   Drug: Methadone Maintenance Therapy

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years